• +886-3-5797779 Fax.105

Recombinant SARS-CoV-2 nucleocapsid protein (AT-P-03)

Key features:

  1. Monoclonal antibody from synthetic antibody libraries developed by AnTaimmu BioMed
  2. High affinity with spike (S) glycoprotein of SARS-COV-2
  3. Suitable for ELISA application
  4. IgG1 isotype

Datasheets   Contact us for MSDS

Categories: ,

Description

Product name

Recombinant SARS-CoV-2 nucleocapsid protein (AT-P-03)

Catalog number

ATBM-P-03

Source

SARS-CoV-2

MW (kDa)

46 kDa

Expression System

HEK293 cells

General notes

Background Information

Coronaviruses are enveloped positive-sense RNA viruses. The most prominent feature of coronaviruses is the club-shape spike projecting from the surface of the virion. Human coronaviruses, first identified in the mid-1960s, are a large family of viruses that cause illness ranging from the common cold to more severe diseases such as Middle East Respiratory Syndrome (MERS-CoV), Severe Acute Respiratory Syndrome (SARS-CoV). Moreover, coronavirus disease 2019 (COVID-19) is an infectious disease caused by the virus strain severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a virus closely related to the SARS virus. A SARS-CoV-2 nucleocapsid antigen can be used to support the detection of SARS-CoV-2 (COVID-19, 2019-nCoV).

Properties

Form

Liquid

Storage instructions

Store at -20oC

Storage buffer

PBS

Purification

Affinity purified by Ni column performance

Contains

N/A

Conjugate

Unconjugated

Clonality

Fusion protein

Validated Applications

Applications Dilution
ELISA 1:1000~1:10000

Showing the single result
Show per page
  • Anti-Human ACE2 monoclonal antibody (AT-ACE2-2)

REFERENCES

Reviews & Q/A

en_USEnglish